{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:33:10Z","timestamp":1791534790297,"version":"4.3.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04450-1","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:33:39Z","timestamp":1781598819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Collagen remodeling in breast cancer progression: from molecular mechanisms to diagnostic and therapeutic opportunities"],"prefix":"10.1007","author":[{"given":"Mina","family":"Mohammad-Rezaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Shafaghat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Noroozbeygi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Periyannan","family":"Velu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumeh","family":"Safaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeime","family":"Heiranizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0517-5948","authenticated-orcid":false,"given":"Elahe","family":"Safari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"11","key":"4450_CR1","doi-asserted-by":"publisher","first-page":"e2443198","DOI":"10.1001\/jamanetworkopen.2024.43198","volume":"7","author":"HM Bizuayehu","year":"2050","unstructured":"Bizuayehu HM, et al. Global disparities of cancer and its projected burden in 2050. JAMA Netw Open. 2050;7(11):e2443198.","journal-title":"JAMA Netw Open"},{"key":"4450_CR2","doi-asserted-by":"publisher","first-page":"106535","DOI":"10.1016\/j.intimp.2020.106535","volume":"84","author":"K Barzaman","year":"2020","unstructured":"Barzaman K, et al. Breast cancer: Biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"4450_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/14737159.2018.1439382","volume":"18","author":"S Mittal","year":"2018","unstructured":"Mittal S, Brown NJ, Holen I. The breast tumor microenvironment: Role in cancer development, progression and response to therapy. Expert Rev Mol Diagn. 2018;18(3):227\u201343.","journal-title":"Expert Rev Mol Diagn"},{"issue":"16","key":"4450_CR4","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921-r925.","journal-title":"Curr Biol"},{"issue":"5","key":"4450_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/cac2.12294","volume":"42","author":"H Zhou","year":"2022","unstructured":"Zhou H, et al. Functions and clinical significance of mechanical tumor microenvironment: Cancer cell sensing, mechanobiology and metastasis. Cancer Commun. 2022;42(5):374\u2013400.","journal-title":"Cancer Commun"},{"key":"4450_CR6","doi-asserted-by":"publisher","first-page":"115390","DOI":"10.1016\/j.biopha.2023.115390","volume":"166","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, et al. Collagen code in tumor microenvironment: functions, molecular mechanisms, and therapeutic implications. Biomed Pharmacother. 2023;166:115390.","journal-title":"Biomed Pharmacother"},{"key":"4450_CR7","doi-asserted-by":"publisher","first-page":"1284962","DOI":"10.3389\/fonc.2023.1284926","volume":"13","author":"R Xu","year":"2023","unstructured":"Xu R, et al. The role of matrix stiffness in breast cancer progression: A review. Frontiers in Oncol. 2023;13:1284962.","journal-title":"Frontiers in Oncol"},{"issue":"1","key":"4450_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12935-024-03385-3","volume":"24","author":"MR Pickett","year":"2024","unstructured":"Pickett MR, et al. Assessing the impact of extracellular matrix fiber orientation on breast cancer cellular metabolism. Cancer Cell Int. 2024;24(1):199.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4450_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-019-2058-1","volume":"17","author":"S Xu","year":"2019","unstructured":"Xu S, Xu H, et al. The role of collagen in cancer: From bench to bedside. J Transl Med. 2019;17(1):309.","journal-title":"J Transl Med"},{"issue":"1","key":"4450_CR10","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, et al. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11(1):5120.","journal-title":"Nat Commun"},{"key":"4450_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091221","author":"NF Brown","year":"2019","unstructured":"Brown NF, Marshall JF. Integrin-mediated TGF\u03b2 activation modulates the tumour microenvironment. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11091221.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4450_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1186\/s12967-022-03768-y","volume":"20","author":"B Deng","year":"2022","unstructured":"Deng B, et al. Biological role of matrix stiffness in tumor growth and treatment. J Transl Med. 2022;20(1):540.","journal-title":"J Transl Med"},{"key":"4450_CR13","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.2147\/IJGM.S463649","volume":"2024","author":"X Li","year":"2024","unstructured":"Li X, Jin Y, Xue J. Unveiling collagen\u2019s role in breast cancer: insights into expression patterns, functions and clinical implications. Int J Gen Med. 2024;2024:1773\u201387.","journal-title":"Int J Gen Med"},{"issue":"139","key":"4450_CR14","first-page":"211","volume":"25","author":"J Liu","year":"2018","unstructured":"Liu J, et al. Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. Discov Med. 2018;25(139):211\u201323.","journal-title":"Discov Med"},{"issue":"8","key":"4450_CR15","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2217\/fon.12.79","volume":"8","author":"KB Chapman","year":"2012","unstructured":"Chapman KB, et al. COL10A1 expression is elevated in diverse solid tumor types and is associated with tumor vasculature. Future Oncol. 2012;8(8):1031\u201340.","journal-title":"Future Oncol"},{"issue":"1","key":"4450_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201801651","volume":"31","author":"A Sorushanova","year":"2019","unstructured":"Sorushanova A, et al. The collagen suprafamily: From biosynthesis to advanced biomaterial development. Adv Mater. 2019;31(1):e1801651.","journal-title":"Adv Mater"},{"issue":"17","key":"4450_CR17","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1091\/mbc.E19-12-0709","volume":"31","author":"VW Tang","year":"2020","unstructured":"Tang VW. Collagen, stiffness, and adhesion: The evolutionary basis of vertebrate mechanobiology. Mol Biol Cell. 2020;31(17):1823\u201334.","journal-title":"Mol Biol Cell"},{"key":"4450_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1201\/9781351070799-5","volume-title":"Collagen","author":"EJ Miller","year":"2018","unstructured":"Miller EJ. Collagen types: structure, distribution, and functions. In: Collagen. CRC Press; 2018. p. 139\u201356."},{"key":"4450_CR19","doi-asserted-by":"publisher","first-page":"1549797","DOI":"10.3389\/fonc.2025.1549797","volume":"15","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, et al. The role of various collagen types in tumor biology: a review. Front Oncol. 2025;15:1549797.","journal-title":"Front Oncol"},{"issue":"2","key":"4450_CR20","first-page":"122","volume":"42","author":"F Li","year":"2020","unstructured":"Li F, Fan J, Ma B. Effect of high expression of type \u2160 collagen \u03b11 chain protein on the prognosis of triple negative breast cancer. Zhonghua Zhong liu za zhi [Chin J Oncol]. 2020;42(2):122\u20136.","journal-title":"Zhonghua Zhong liu za zhi [Chin J Oncol]"},{"key":"4450_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10585-021-10082-2","volume":"38","author":"M Lindgren","year":"2021","unstructured":"Lindgren M, et al. Type IV collagen as a potential biomarker of metastatic breast cancer. Clin Exp Metas. 2021;38:175\u201385.","journal-title":"Clin Exp Metas"},{"key":"4450_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.593874","volume":"8","author":"C Onursal","year":"2021","unstructured":"Onursal C, et al. Collagen biosynthesis, processing, and maturation in lung ageing. Front Med. 2021;8:593874.","journal-title":"Front Med"},{"key":"4450_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147867","volume":"892","author":"N Salimian","year":"2024","unstructured":"Salimian N, et al. Collagen 1A1 (COL1A1) and Collagen11A1 (COL11A1) as diagnostic biomarkers in breast, colorectal and gastric cancers. Gene. 2024;892:147867.","journal-title":"Gene"},{"issue":"17","key":"4450_CR24","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1038\/s41388-022-02258-1","volume":"41","author":"T Koorman","year":"2022","unstructured":"Koorman T, et al. Spatial collagen stiffening promotes collective breast cancer cell invasion by reinforcing extracellular matrix alignment. Oncogene. 2022;41(17):2458\u201369.","journal-title":"Oncogene"},{"key":"4450_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010198","author":"H Fujisaki","year":"2022","unstructured":"Fujisaki H. Epithelial-mesenchymal transition induced in cancer cells by adhesion to type I collagen. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms24010198.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4450_CR26","doi-asserted-by":"publisher","first-page":"a005058","DOI":"10.1101\/cshperspect.a005058","volume":"3","author":"P Lu","year":"2011","unstructured":"Lu P, et al. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. 2011;3(12):a005058.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4450_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100528","author":"A Naba","year":"2023","unstructured":"Naba A. Ten years of extracellular matrix proteomics: accomplishments, challenges and future perspectives. Mol Cell Proteomics. 2023. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100528.","journal-title":"Mol Cell Proteomics"},{"key":"4450_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051046","author":"J Martinez","year":"2021","unstructured":"Martinez J, Smith JandPC. The dynamic interaction between extracellular matrix remodeling and breast tumor progression. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10051046.","journal-title":"Cells"},{"key":"4450_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810509","author":"K Song","year":"2022","unstructured":"Song K, et al. Collagen remodeling along cancer progression providing a novel opportunity for cancer diagnosis and treatment. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms231810509.","journal-title":"Int J Mol Sci"},{"key":"4450_CR30","doi-asserted-by":"publisher","first-page":"1108695","DOI":"10.3389\/fonc.2022.1108695","volume":"12","author":"MJ Kwon","year":"2022","unstructured":"Kwon MJ. Matrix metalloproteinases as therapeutic targets in breast cancer. Front Oncol. 2022;12:1108695.","journal-title":"Front Oncol"},{"issue":"1","key":"4450_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07615-y","volume":"16","author":"L Chen","year":"2025","unstructured":"Chen L, et al. MMP1-induced NF-\u03baB activation promotes epithelial-mesenchymal transition and sacituzumab govitecan resistance in hormone receptor-positive breast cancer. Cell Death Dis. 2025;16(1):346.","journal-title":"Cell Death Dis"},{"key":"4450_CR32","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","volume":"9","author":"S Quintero-Fabi\u00e1n","year":"2019","unstructured":"Quintero-Fabi\u00e1n S, et al. Role of matrix metalloproteinases in angiogenesis and cancer. Front Oncol. 2019;9:1370.","journal-title":"Front Oncol"},{"issue":"1","key":"4450_CR33","doi-asserted-by":"publisher","first-page":"8678","DOI":"10.1038\/s41598-017-09062-y","volume":"7","author":"LD Moore-Smith","year":"2017","unstructured":"Moore-Smith LD, et al. Silencing of TGF-\u03b21 in tumor cells impacts MMP-9 in tumor microenvironment. Sci Rep. 2017;7(1):8678.","journal-title":"Sci Rep"},{"issue":"8","key":"4450_CR34","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3319","volume":"12","author":"HE Barker","year":"2012","unstructured":"Barker HE, Cox TR, Erler JT. The rationale for targeting the LOX family in cancer. Nat Rev Cancer. 2012;12(8):540\u201352.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4450_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12964-025-02176-1","volume":"23","author":"Q Xu","year":"2025","unstructured":"Xu Q, et al. Machine learning-based in-silico analysis identifies signatures of lysyl oxidases for prognostic and therapeutic response prediction in cancer. Cell Commun Signal. 2025;23(1):169.","journal-title":"Cell Commun Signal"},{"issue":"6","key":"4450_CR36","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1158\/0008-5472.CAN-12-2233","volume":"73","author":"TR Cox","year":"2013","unstructured":"Cox TR, et al. LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res. 2013;73(6):1721\u201332.","journal-title":"Cancer Res"},{"key":"4450_CR37","doi-asserted-by":"publisher","first-page":"883998","DOI":"10.3389\/fphar.2022.883998","volume":"13","author":"S Ramos","year":"2022","unstructured":"Ramos S, et al. Lysyl oxidases expression and breast cancer progression: a bioinformatic analysis. Front Pharmacol. 2022;13:883998.","journal-title":"Front Pharmacol"},{"issue":"12","key":"4450_CR38","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243\u201353.","journal-title":"EMBO Rep"},{"issue":"11","key":"4450_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2019.08.004","volume":"1863","author":"SB Bansode","year":"2019","unstructured":"Bansode SB, Gacche RN. Glycation-induced modification of tissue-specific ECM proteins: A pathophysiological mechanism in degenerative diseases. Biochim Biophys Acta Gen Subj. 2019;1863(11):129411.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"4450_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136162","author":"A Rella","year":"2025","unstructured":"Rella A, et al. Fructose-induced glycation end products promote skin-aging phenotypes and senescence marker expression in human dermal fibroblasts. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26136162.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4450_CR41","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.ajpath.2010.11.076","volume":"178","author":"MW Conklin","year":"2011","unstructured":"Conklin MW, et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol. 2011;178(3):1221\u201332.","journal-title":"Am J Pathol"},{"key":"4450_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cells12232688","author":"S Poonja","year":"2023","unstructured":"Poonja S, et al. Dynamics of fibril collagen remodeling by tumor cells: A model of tumor-associated collagen signatures. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12232688.","journal-title":"Cells"},{"key":"4450_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.matbio.2023.05.006","volume":"121","author":"T Wu","year":"2023","unstructured":"Wu T, et al. Matrix stiffening facilitates the collective invasion of breast cancer through the periostin-integrin mechanotransduction pathway. Matrix Biol. 2023;121:22\u201340.","journal-title":"Matrix Biol"},{"issue":"4","key":"4450_CR44","doi-asserted-by":"publisher","first-page":"C1212","DOI":"10.1152\/ajpcell.00633.2023","volume":"326","author":"JH Longstreth","year":"2024","unstructured":"Longstreth JH, Wang K. The role of fibronectin in mediating cell migration. Am J Physiol Cell Physiol. 2024;326(4):C1212\u201325.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4450_CR45","doi-asserted-by":"publisher","first-page":"1456636","DOI":"10.3389\/fimmu.2024.1456636","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, et al. Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: A magic key. Front Immunol. 2024;15:1456636.","journal-title":"Front Immunol"},{"key":"4450_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012415","author":"L Necula","year":"2022","unstructured":"Necula L, et al. Collagen family as promising biomarkers and therapeutic targets in cancer. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232012415.","journal-title":"Int J Mol Sci"},{"issue":"29","key":"4450_CR47","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1200\/JCO.22.01002","volume":"40","author":"HS Rugo","year":"2022","unstructured":"Rugo HS, et al. Sacituzumab govitecan in hormone receptor-positive\/human epidermal growth factor receptor 2-negative metastatic breast cancer. J Clin Oncol. 2022;40(29):3365\u201376.","journal-title":"J Clin Oncol"},{"key":"4450_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-4-38","volume":"4","author":"PP Provenzano","year":"2006","unstructured":"Provenzano PP, et al. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006;4:1\u201315.","journal-title":"BMC Med"},{"issue":"8","key":"4450_CR49","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3390\/ijms18081772","volume":"18","author":"L Mosta\u00e7o-Guidolin","year":"2017","unstructured":"Mosta\u00e7o-Guidolin L, Rosin NL, Hackett T-L. Imaging collagen in scar tissue: Developments in second harmonic generation microscopy for biomedical applications. Int J Mol Sci. 2017;18(8):1772.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4450_CR50","first-page":"37","volume":"4","author":"H Kasban","year":"2015","unstructured":"Kasban H, El-Bendary M, Salama D. A comparative study of medical imaging techniques. Int J Inf Sci Intell Syst. 2015;4(2):37\u201358.","journal-title":"Int J Inf Sci Intell Syst"},{"key":"4450_CR51","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201900304","author":"U Blache","year":"2019","unstructured":"Blache U, et al. Mesenchymal stromal cell activation by breast cancer secretomes in bioengineered 3D microenvironments. Life Sci Alliance. 2019. https:\/\/doi.org\/10.26508\/lsa.201900304.","journal-title":"Life Sci Alliance"},{"key":"4450_CR52","first-page":"1","volume":"43","author":"LA Filgueiras","year":"2024","unstructured":"Filgueiras LA, et al. Analysis of SIKVAV\u2019s receptor affinity, pharmacokinetics, and pharmacological characteristics: A matrikine with potent biological function. J Biomol Str Dyn. 2024;43:1\u201323.","journal-title":"J Biomol Str Dyn."},{"issue":"1","key":"4450_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.gendis.2014.12.002","volume":"2","author":"J Cathcart","year":"2015","unstructured":"Cathcart J, Pulkoski-Gross A, Cao J. Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas. Genes Dis. 2015;2(1):26\u201334.","journal-title":"Genes Dis"},{"issue":"1","key":"4450_CR54","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12967-024-05199-3","volume":"22","author":"R Borst","year":"2024","unstructured":"Borst R, Meyaard L. Understanding the matrix: collagen modifications in tumors and their implications for immunotherapy. J Transl Med. 2024;22(1):382.","journal-title":"J Transl Med"},{"issue":"12","key":"4450_CR55","doi-asserted-by":"publisher","first-page":"6805","DOI":"10.1021\/acsbiomaterials.3c01332","volume":"9","author":"JS Passos","year":"2023","unstructured":"Passos JS, Lopes LB, Panitch A. Collagen-binding nanoparticles for paclitaxel encapsulation and breast cancer treatment. ACS Biomater Sci Eng. 2023;9(12):6805\u201320.","journal-title":"ACS Biomater Sci Eng"},{"key":"4450_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225487","author":"I Druzhkova","year":"2022","unstructured":"Druzhkova I, et al. Effect of collagen matrix on doxorubicin distribution and cancer cells\u2019 response to treatment in 3D tumor model. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14225487.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4450_CR57","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41467-020-16199-4","volume":"11","author":"O Saatci","year":"2020","unstructured":"Saatci O, et al. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nat Commun. 2020;11(1):2416.","journal-title":"Nat Commun"},{"issue":"1","key":"4450_CR58","first-page":"86","volume":"10","author":"DC Stewart","year":"2024","unstructured":"Stewart DC, et al. Prognostic and therapeutic implications of tumor-restrictive type III collagen in the breast cancer microenvironment. NPJ Cancer. 2024;10(1):86.","journal-title":"NPJ Cancer"},{"key":"4450_CR59","doi-asserted-by":"publisher","DOI":"10.1172\/JCI155148","author":"LA Horn","year":"2022","unstructured":"Horn LA, et al. Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-\u03b2 signaling enables PD-L1-mediated tumor eradication. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI155148.","journal-title":"J Clin Invest"},{"issue":"1","key":"4450_CR60","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12964-018-0309-z","volume":"16","author":"JY He","year":"2018","unstructured":"He JY, et al. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression. Cell Commun Signal. 2018;16(1):100.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"4450_CR61","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","volume":"20","author":"A Totaro","year":"2018","unstructured":"Totaro A, Panciera T, Piccolo S. YAP\/TAZ upstream signals and downstream responses. Nat Cell Biol. 2018;20(8):888\u201399.","journal-title":"Nat Cell Biol"},{"issue":"21","key":"4450_CR62","doi-asserted-by":"publisher","first-page":"11636","DOI":"10.3390\/ijms222111636","volume":"22","author":"E Elwakeel","year":"2021","unstructured":"Elwakeel E, Weigert A. Breast cancer CAFs: spectrum of phenotypes and promising targeting avenues. Int J Mol Sci. 2021;22(21):11636.","journal-title":"Int J Mol Sci"},{"issue":"570","key":"4450_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aav5183","volume":"12","author":"R Derynck","year":"2019","unstructured":"Derynck R. Specificity, versatility and control of TGF-\u03b2 family signaling. Sci Signal. 2019;12(570):eaav5183.","journal-title":"Sci Signal"},{"issue":"3","key":"4450_CR64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1634\/theoncologist.2017-0024","volume":"22","author":"AB Benson 3rd","year":"2017","unstructured":"Benson AB 3rd, et al. A phase II randomized, double-blind, placebo-controlled study of simtuzumab or placebo in combination with gemcitabine for the first-line treatment of pancreatic adenocarcinoma. Oncologist. 2017;22(3):241-e15.","journal-title":"Oncologist"},{"key":"4450_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10020312","author":"S Ferreira","year":"2021","unstructured":"Ferreira S, et al. LOXL2 inhibitors and breast cancer progression. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox10020312.","journal-title":"Antioxidants"},{"issue":"3","key":"4450_CR66","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.cardiores.2005.11.032","volume":"69","author":"JT Peterson","year":"2006","unstructured":"Peterson JT. The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors. Cardiovasc Res. 2006;69(3):677\u201387.","journal-title":"Cardiovasc Res"},{"key":"4450_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/targets3010008","author":"A Shoari","year":"2025","unstructured":"Shoari A. From bench to bedside: transforming cancer therapy with protease inhibitors. Targets. 2025. https:\/\/doi.org\/10.3390\/targets3010008.","journal-title":"Targets"},{"key":"4450_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1108695","author":"MJ Kwon","year":"2023","unstructured":"Kwon MJ. Matrix metalloproteinases as therapeutic targets in breast cancer. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2022.1108695.","journal-title":"Front Oncol"},{"issue":"41","key":"4450_CR69","doi-asserted-by":"publisher","first-page":"16618","DOI":"10.1073\/pnas.1117610109","volume":"109","author":"J Liu","year":"2012","unstructured":"Liu J, et al. TGF-\u03b2 blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma. Proc Natl Acad Sci U S A. 2012;109(41):16618\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4450_CR70","first-page":"149","volume":"2","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Yu N, Lee C. Vicious cycle of TGF-\u03b2 signaling in tumor progression and metastasis. Am J Clin Exp Urol. 2014;2(2):149\u201355.","journal-title":"Am J Clin Exp Urol"},{"issue":"1","key":"4450_CR71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41568-022-00527-5","volume":"23","author":"D Entenberg","year":"2023","unstructured":"Entenberg D, Oktay MH, Condeelis JS. Intravital imaging to study cancer progression and metastasis. Nat Rev Cancer. 2023;23(1):25\u201342.","journal-title":"Nat Rev Cancer"},{"key":"4450_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-025-01523-w","author":"N Yao","year":"2025","unstructured":"Yao N, et al. Patient-derived tumor organoids for cancer immunotherapy: Culture techniques and clinical application. Invest New Drugs. 2025. https:\/\/doi.org\/10.1007\/s10637-025-01523-w.","journal-title":"Invest New Drugs"},{"issue":"12","key":"4450_CR73","doi-asserted-by":"publisher","first-page":"100909","DOI":"10.1016\/j.crmeth.2024.100909","volume":"4","author":"BP Sharpe","year":"2024","unstructured":"Sharpe BP, et al. Patient-derived tumor organoid and fibroblast assembloid models for interrogation of the tumor microenvironment in esophageal adenocarcinoma. Cell Rep Methods. 2024;4(12):100909.","journal-title":"Cell Rep Methods"},{"key":"4450_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21061951","author":"S Guerrero-Aspizua","year":"2020","unstructured":"Guerrero-Aspizua S, et al. Humanization of tumor stroma by tissue engineering as a tool to improve squamous cell carcinoma xenograft. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21061951.","journal-title":"Int J Mol Sci"},{"issue":"36","key":"4450_CR75","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1038\/s41388-018-0320-2","volume":"37","author":"L Rossow","year":"2018","unstructured":"Rossow L, et al. LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy. Oncogene. 2018;37(36):4921\u201340.","journal-title":"Oncogene"},{"key":"4450_CR76","doi-asserted-by":"publisher","first-page":"925165","DOI":"10.3389\/fonc.2022.925165","volume":"12","author":"YH Wu","year":"2022","unstructured":"Wu YH. Collagen XI alpha 1 chain, a novel therapeutic target for cancer treatment. Front Oncol. 2022;12:925165.","journal-title":"Front Oncol"},{"issue":"8","key":"4450_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236516","volume":"15","author":"S Rosen","year":"2020","unstructured":"Rosen S, et al. Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma. PLoS ONE. 2020;15(8):e0236516.","journal-title":"PLoS ONE"},{"issue":"3","key":"4450_CR78","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/intbio\/zyz011","volume":"11","author":"YJ Suh","year":"2019","unstructured":"Suh YJ, et al. Glycation of collagen matrices promotes breast tumor cell invasion. Integr Biol (Camb). 2019;11(3):109\u201317.","journal-title":"Integr Biol (Camb)"},{"issue":"4","key":"4450_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.125","volume":"3","author":"D Wang","year":"2024","unstructured":"Wang D, et al. Identification of collagen subtypes of gastric cancer for distinguishing patient prognosis and therapeutic response. Cancer Innovation. 2024;3(4):e125.","journal-title":"Cancer Innovation"},{"key":"4450_CR80","doi-asserted-by":"publisher","first-page":"100364","DOI":"10.1016\/j.mtbio.2022.100364","volume":"16","author":"M Li","year":"2022","unstructured":"Li M, et al. Tumor extracellular matrix modulating strategies for enhanced antitumor therapy of nanomedicines. Mater Today Bio. 2022;16:100364.","journal-title":"Mater Today Bio"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04450-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04450-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04450-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:01:19Z","timestamp":1781650879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04450-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":80,"alternative-id":["4450"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04450-1","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that none of their known financial conflicts or interpersonal connections might have influenced the work that was published in this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"As this article is a review study and does not involve human participants or animals, ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}